Drug
Cdx 301
Cdx 301: highest development phase Phase 1, developed by Celldex Therapeutics, United Therapeutics. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Celldex Therapeutics, United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| CDX-301 NCT04930783 | Phase 1 | Melanoma |
| CDX-301 NCT01465139 | Phase 1 | Healthy |
Latest
No recent events.
Follow Cdx 301 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.